Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Hyperfiction as performance art.
Drug companies make millions on lifestyle potions. Is R&D on more vital therapies lagging?
A vial of bacteria capable of computation? Injectable cells that survey the bloodstream and produce drugs on demand? These ideas might not be as far-fetched as they sound.
A DNA mismatch raises fears.
This chemist’s dream is to understand how the human body works - molecule by molecule.
Bob Swanson, the founder of Genentech, embodied virtues that today’s venture capitalists are badly in need of.
After a decade of disappointment and a teenager’s death, this experimental treatment faces a crucial test. Can it cure hemophilia?